Press Releases Crossject Deutsche Boerse AG

Equities

74C

FR0011716265

Market Closed - Deutsche Boerse AG Other stock markets 02:02:11 2024-07-16 EDT			5-day change	1st Jan Change
1.826 ^EUR	+2.70%		+16.16%	-59.78%

07-10	Markets Powered by Alternating Current
07-10	Crossject Gets EUR7 Million Public Funding for New Epinephrine Product	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Crossject to attend H.C. Wainwright 26th Annual Global Investment Conference	07-15	GL
Crossject is awarded a 6.9 million euros financing from the French Government, as part of the France 2030 innovation plan, to accelerate the development of ZENEO® Epinephrine	07-10	GL
Crossject elaborates on ZEPIZURE potential in light of landmark RAMPART study and its own, recently published, bioequivalence study	06-27	AQ
Crossject elaborates on ZEPIZURE® potential in light of landmark RAMPART study and its own, recently published, bioequivalence study	06-26	GL
Crossject appoints Dan Chiche, MD as Chief Medical Officer North America	06-12	GL
Crossject appoints Dan Chiche, MD as Chief Medical Officer North America	06-12	AQ
Crossject announces highly successful closing of its €8 million rights offering	06-04	GL
Crossject announces publication of clinical data on ZEPIZURE ® in Neurology and Therapy	05-30	GL
Crossject signs a geographic extension of ZEPIZURE® commercialization agreement in Europe	05-02	GL
Crossject reports audited financial results for 2023	04-25	GL
Crossject trading on Euronext to resume as usual on Wednesday April 3	04-02	GL
Crossject advances in its U.S. Strategy and reports Financial Results for 2023	04-02	GL
Crossject gender equality score reaches 96/100 in 2024	03-08	GL
Crossject gender equality score reaches 96/100 in 2024	03-08	AQ
Crossject obtains a financing up to €12 million, in two tranches	02-27	GL
Crossject obtains a financing up to €12 million, in two tranches	02-27	AQ
Crossject provides strategic update on priorities for 2024	02-06	GL
Crossject provides strategic update on priorities for 2024	02-06	AQ
Crossject to host a business briefing on commercial strategy on February 6 at 17:30 CET	02-01	GL
Crossject to host a business briefing on commercial strategy on February 6 at 17:30 CET	02-01	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Crossject Deutsche Boerse AG

Equities

74C

FR0011716265

Press Releases

Filters